Announcements Trials

Browse Landscape

Phase

Phase 1 11 Phase 2 10 Phase 1/2 8 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 190 Lung Neoplasms 67 Ovarian Neoplasms 64 Breast Neoplasms 38 Fallopian Tube Neoplasms 33 Small Cell Lung Carcinoma 31 Parkinson Disease 4, Autosomal Dominant Lewy Body 27 Carcinoma, Ovarian Epithelial 24 Uterine Cervical Neoplasms 22 Triple Negative Breast Neoplasms 22 Squamous Cell Carcinoma of Head and Neck 19 Neuroblastoma 17 Carcinoma 17 Adenocarcinoma of Lung 17 Neoplasm Metastasis 15 Endometrial Neoplasms 14 Neoplasms 12 Head and Neck Neoplasms 11 Recurrence 8 Peritoneal Neoplasms 8 Carcinoma, Transitional Cell 8 Esophageal Neoplasms 7 Central Nervous System Neoplasms 7 Brenner Tumor 7 Urinary Bladder Neoplasms 6 Lung Diseases 6 Adenocarcinoma, Bronchiolo-Alveolar 6 Thoracic Neoplasms 5 Testicular Neoplasms 5 Respiratory Tract Neoplasms 5

Interventions

Oxaliplatin 56 Capecitabine 49 Fluorouracil 37 Cisplatin 37 S 1 (combination) 23 Paclitaxel 18 Docetaxel 18 Leucovorin 16 pembrolizumab 13 Irinotecan 12 apatinib 11 titanium silicide 9 XELOX 9 Trastuzumab 9 Nivolumab 9 Hyperthermic Intraperitoneal Chemotherapy 8 Epirubicin 8 Drug Therapy 8 Tegafur 7 Radiotherapy 6 Neoadjuvant Therapy 6 gimeracil 5 Surgical Procedures, Operative 5 Gastrectomy 5 Chemotherapy, Adjuvant 5 tislelizumab 4 S-1 plus cisplatin 4 Ramucirumab 4 zolbetuximab 3 sintilimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Stomach Neoplasms × Carboplatin × Clear all

NCT00718354 2015-05-13

GASTRANOX

Thrombosis Research Institute

Phase 3 Completed

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡